BK

Bhupendra Kapadia

Director Director DIN 02490765
DIN 02490765 First appointment Jul 1987 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Jul 1987
Shareholding value •••• Premium profile

About Bhupendra Kapadia

Data last updated:

Bhupendra Kapadia was a Director at Bio Speciality Assay Lab Private Limited (1987–2009) and Director at B.A.B. Agencies Private Limited (1987–2011). The companies operate in Healthcare.

DIN 02490765
Primary Designation Director
Industry Healthcare
First Appointment 06 Jul 1987

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director06 Jul 19871987₹2.23 Cr (FY 2025)Active
B.A.B. Agencies Private Limited U51109WB1987PTC042643
Director06 Jul 19871987₹1.3 Lakh (FY 2023)Converted To Llp

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Bio Speciality Assay Lab Private Limited
B.A.B. Agencies Private Limited
Premium access

Shareholding and investment profile for Bhupendra Kapadia

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bhupendra Kapadia

Bhupendra Kapadia was first appointed on 06 Jul 1987 as Director at Bio Speciality Assay Lab Private Limited.

Bhupendra Kapadia held 2 earlier board appointments: Bio Speciality Assay Lab Private Limited (Director, 06 Jul 1987 to 30 Sep 2009); B.A.B. Agencies Private Limited (Director, 06 Jul 1987 to 25 Jun 2011).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available